Privia Health Group (NASDAQ:PRVA) CEO Parth Mehrotra Sells 27,229 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 27,229 shares of the stock in a transaction on Friday, March 13th. The shares were sold at an average price of $21.52, for a total transaction of $585,968.08. Following the transaction, the chief executive officer owned 581,952 shares of the company’s stock, valued at $12,523,607.04. This trade represents a 4.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Parth Mehrotra also recently made the following trade(s):

• On Thursday, March 12th, Parth Mehrotra sold 26,763 shares of Privia Health Group stock. The stock was sold at an average price of $21.90, for a total transaction of $586,109.70.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The shares were sold at an average price of $22.71, for a total transaction of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The shares were sold at an average price of $22.86, for a total transaction of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $21.96 on Tuesday. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The business’s 50 day moving average is $22.85 and its two-hundred day moving average is $23.62. The stock has a market capitalization of $2.72 billion, a P/E ratio of 129.18, a PEG ratio of 1.37 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings data on Thursday, February 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.21. The business had revenue of $541.17 million during the quarter, compared to analyst estimates of $516.61 million. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The company’s revenue for the quarter was up 17.4% on a year-over-year basis. During the same period last year, the company earned $0.21 EPS. As a group, equities research analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PRVA. Stephens restated an “overweight” rating and issued a $32.00 price target on shares of Privia Health Group in a research report on Thursday, December 4th. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, February 27th. Jefferies Financial Group restated a “buy” rating and issued a $32.00 target price on shares of Privia Health Group in a report on Thursday, February 26th. Wolfe Research set a $31.00 price target on shares of Privia Health Group in a research note on Tuesday, January 6th. Finally, Piper Sandler reiterated an “overweight” rating and set a $36.00 price target on shares of Privia Health Group in a report on Thursday, February 26th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $31.00.

Hedge Funds Weigh In On Privia Health Group

A number of large investors have recently bought and sold shares of PRVA. Bayban purchased a new stake in Privia Health Group in the fourth quarter worth $26,000. Hantz Financial Services Inc. lifted its position in shares of Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the last quarter. Global Retirement Partners LLC boosted its stake in shares of Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock valued at $38,000 after purchasing an additional 1,351 shares during the period. Canada Pension Plan Investment Board boosted its stake in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the period. Finally, Kestra Advisory Services LLC bought a new position in shares of Privia Health Group in the fourth quarter worth about $93,000. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.